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predictor of favorable attitudes. Increased training and clinical exposure
may prove to be crucial in raising awareness of the importance of safe
abortion access. The results of this survey will be used to improve the
abortion curriculum and training opportunities.
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Objectives: In a previous evaluation of telemedicine for medication
abortion, patients in Iowa found it highly acceptable. We assessed
the acceptability of telemedicine for medication abortion when
translated to different settings across the United States.
Methods: In-person and telemedicine patients seen at health centers
in seven states completed an online survey approximately 2 weeks
postabortion. χ2 and Kruskal–Wallis tests were used to assess
differences between groups.
Results: Of the 205 in-person and 198 telemedicine participants, the
average age was 26; 42% were single and never married, 77% were
parous, and 45% had had a prior abortion. The vastmajoritywere “very
satisﬁed” with the information received preappointment (80%), the
conversation with the abortion provider (86%), follow-up calls (80%),
birth control information (86%) and overall care (83%); ratings did not
differ by abortion type. More than 98% of telemedicine respondents
could easily see and hear the provider. Although 24% of telemedicine
respondents would have preferred to be in the room with the
provider, of these, 90% were “somewhat” or “very” satisﬁed overall.
More telemedicine than in-person respondents would recommend
services to a friend (87% vs. 76%; p=.014). Age, marital status and
prior abortion were not associated with preferring to be in the same
room as the provider or recommending the service. Strong desire for
medication vs. surgical abortion (72%) and parity were associated
with recommending services (p=.003 and .004).
Conclusions: Patients in diverse settings reported that this scaled-up
model of telemedicine for medication abortion is highly acceptable.
Further work is needed to understand some patients’ desire to be in
the same room as the provider.
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Objectives: We describe fetomaternal hemorrhage during routine
second-trimester dilation and evacuation (D&E) procedures.
Methods: We enrolled 325 women seeking D&E abortion between
15-0/7 and 23-6/7weeks’ gestation. Participants had blood drawnwithin
120 min before and 30–120 min after the procedure. We excluded
women for whom pre- or postsamples could not be obtained or those
who required additional procedures due to hemorrhage. Three techni-
cians performed Kleihauer–Betke acid elution testing on all specimens.
We calculated fetomaternal hemorrhage in ml and the proportion of
such hemorrhage that would require more than 100 mcg and 300 mcg
Rh-immune globulin (hemorrhage of 10 ml and 30 ml, respectively).
Results: The 300 participants in the analysis had a mean gestation of
19-6/7+2-2/7 weeks. The median preprocedure hemorrhage was 0 ml
(range 0–50 ml), and 2 (0.67%) women exceeded 10 ml. The median
postprocedure hemorrhage was 1 ml (range 0–60 ml). Almost all
(n=295, 98.3%) participants had hemorrhage of less than 10 ml,
and 298 (99.3%) had hemorrhage of less than 30 ml. Fetomaternal
hemorrhage quantity was not signiﬁcantly associated with other
factors including gestational age, Rh status, prior cesarean section,
estimated blood loss, procedure time or indication for D&E. All women
(100%) who had the procedure before 18 weeks’ gestation had
hemorrhage of less than 10 ml.
Conclusions: Fetomaternal hemorrhage occurring with routine second-
trimester D&E procedures is minimal and adequately covered by
the amount of Rh-immune globulin given as recommended by UK
(100 mcg) and US (300 mcg) guidelines. This exploratory study is a
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Objectives: Abortion is legal and widely available in Mexico City, but
practices around the sale of misoprostol in community pharmacies
are not well understood. We assessed pharmacy staff sale practices
and knowledge about misoprostol in Mexico City.
Methods: We used data collected from 174 pharmacies in 15
neighborhoods in Mexico City. One staff member at each pharmacy
was asked about indications for misoprostol, as well as sale practices
and social and demographic information. Our primary outcome was
availability of misoprostol. We used descriptive and bivariate
statistics to compare knowledge and practices by type of pharmacy
(chain or small independent) and location.
Results: Of the 174 pharmacies, 65 were chain locations and 109
were small independent locations. Misoprostol was available at 61%
of sites. Only 49% of independent pharmacies sold misoprostol,
compared with 81.5% of chain pharmacies (pb.05). Knowledge of
indications for misoprostol use was similar between independent
and chain pharmacies, though only 13.8% of chain and 8.2% of
independent pharmacy employees correctly identiﬁed at least three
out of ﬁve of the indications. Eighty percent of respondents knew
that abortion was legal in Mexico City, and 44% reported requiring a
prescription for sale of misoprostol.
Conclusions: Availability, knowledge of indications for use of
misoprostol and requirement of a prescription varied widely among
pharmacies, resulting in differential access to medication abortion.
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Pharmaciesmay be a good place to target education for pharmacy staff
and women about safe and effective use of misoprostol for abortion.
doi:10.1016/j.contraception.2018.07.043
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Objectives: Many women who have abortions are already mothers.
However, little research has examined how previous pregnancies and
experiences of parenting shape women’s subsequent abortion-related
decisions and experiences. No research has explored these dynamics
in the Canadian context. Our qualitative study aimed to ﬁll this gap.
Methods: Between 2012 and 2015, we conducted 305 semistructured
interviews with Anglophone and Francophone women from across
Canada who had recently had an abortion. We audio-recorded and
transcribed all interviews and conducted content and thematic
analyses using deductive and inductive techniques. We focus here
on the 94 interviews with mothers who had a subsequent abortion.
Results: The majority of our participants talked explicitly about how
existing children inﬂuenced their decision to have an abortion. Several
shared that having children, and ﬁnding childcare in particular, made
the process of obtaining an abortion harder; this was especially true for
women who obtained hospital-based abortions that required multiple
appointments with different providers over several days. Long wait
times affected how effectively women felt that they were able to parent
when they were pregnant but waiting for their abortion. Finally,
mothers referenced friends, partners and familymemberswhoprovided
childcare during the abortion process as important sources of support.
Conclusions: Mothers discussed compounded challenges in accessing
abortion care and continuing to parent. Our ﬁndings highlight the
importance of streamlining abortion services and suggest that efforts to
reduce wait times and expand the number and location of service
delivery points could meet a signiﬁcant need.
doi:10.1016/j.contraception.2018.07.044
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Objectives: Luker (1984) framed antiabortion beliefs as a political
expression of broader conservative worldviews related to gender.
Since then, antiabortion rhetoric has shifted: from fetal-centric to
“prowoman”; from religious to “evidence” based. This analysis
examines both the explicit messages and implicit assumptions of
antiabortion ﬁlms to consider whether new movement messaging
reﬂects evolving antiabortion worldviews.
Methods: Using a dataset of abortion-related ﬁlms, movie reviews
and published interviews with content creators, we identiﬁed nine
ﬁlms that were both created to promote antiabortion worldviews
and received accordingly by the “prolife” movement. Both authors
viewed the ﬁlms and coded for reproductive decision-making
content. We identiﬁed emergent themes related to gender, sexuality,
relationships, and race and used deductive and inductive code lists to
clarify the overarching themes of the antiabortion paradigm.
Results: Antiabortion ﬁlms used rhetorical frames that endorse misinfor-
mation, elevate the fetus and emphasize “natural” gender roles (including
motherhood and fatherhood). Notably, the ﬁlms invoked racial stereo-
types (e.g., “Magical Negro,” “mammy” and “white savior” tropes) and
relied heavily on themes of Christian persecution and forgiveness.
Conclusions: These movies reveal that newer antiabortion messaging
does not reﬂect an updated antiabortion worldview. “Prowoman”
messages are rooted in an understanding of womanhood that requires
protection; forgiveness is rooted in religious ideologies of sin and
redemption; abortion misinformation is rooted in the belief that
conservative intuition is a better source of knowledge than scientiﬁc
consensus. The antiabortion worldview remains consistent even as
movement messages shift, and is rooted in conservative ideologies
around not only gender, sex, and religion but also race.
doi:10.1016/j.contraception.2018.07.045
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Objectives: We aimed to assess side effects of prophylactic oral
metronidazole, doxycycline and azithromycin vs. placebo among
women undergoing surgical abortion. A substudy assessed serum
drug levels and utility of endometrial cultures to examine bacterial
burden after surgical abortion.
Methods: We randomized 180 subjects undergoing surgical abortion
among four groups: metronidazole 500 mg, azithromycin 500 mg,
doxycycline 200 mg or placebo (with azithromycin prior to discharge).
Outcomes were assessed via questionnaire before and after uterine
aspiration. We drew blood from substudy participants and collected
endometrial culture swabs immediately following the abortion.
Results: We analyzed complete results for 171 subjects and found no
differences in demographic characteristics or baseline nausea or
vomiting. Preoperatively, 14%–25% reported any nausea, and four
vomited. This did not differ by antibiotic. Postoperatively, 14%–30%
reported nausea, which also did not differ by antibiotic regimen. Nine
women vomited, six (15%) of whom received doxycycline and three
(7%) of whom who received azithromycin. Participants who received
doxycycline were more likely to vomit than those who received either
placebo or metronidazole (p=.01). No infections were reported at 1-
week follow-up. Of the 33 cultures available, 13 showed growth of
predominantly gram-positive bacteria, and 20 showed no growth.
There was no correlation between group assignment and bacterial
growth. Serum antibiotic levels varied, were frequently subtherapeutic
and did not affect culture growth.
Conclusions: Women tolerated single-dose prophylactic antibiotics
with few side effects. Doxycycline caused slightly more vomiting after
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